Stephen B. Liggett
22Patents
6h-index
23Co-inventors
69Inventor score
Filing activity: Oct 10, 1997 → Sep 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7572603B2 | Alpha-2 adrenergic receptor polymorphisms | Chemistry; Metallurgy | 56 | Active |
| US7678824B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 10 | Active |
| US6861217B1 | Variation in drug response related to polymorphisms in the β2-adrenergic receptor | Chemistry; Metallurgy | 8 | Expired |
| US6498009B1 | &bgr;-adrenergic receptor polymorphisms | Chemistry; Metallurgy | 7 | Expired |
| US6586183B2 | Association of &bgr;2-adrenergic receptor haplotypes with drug response | Chemistry; Metallurgy | 6 | Expired |
| US7449292B2 | Methods for predicting relative efficacy of a beta blocker therapy based on a B1-adrenergic receptor polymorphism | Chemistry; Metallurgy | 6 | Expired |
| US7041810B2 | Alpha-2 adrenergic receptor polymorphisms | Chemistry; Metallurgy | 5 | Expired |
| US6797472B1 | Variation in drug response related to polymorphisms in &bgr;2-adrenergic receptor | Chemistry; Metallurgy | 4 | Expired |
| US8093286B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 4 | Active |
| US6316188A | Histamine-N-methyltransferase variants associated with histaminergic disease | Chemistry; Metallurgy | 4 | Expired |
| US7229756B1 | Alpha-2B-adrenergic receptor polymorphisms | Chemistry; Metallurgy | 3 | Expired |
| US9579315B2 | Methods of treating obstructive lung diseases using bitter tastants | Physics | 3 | Active |
| US7642052B2 | Heart failure assessment based on alpha-2C adrenergic receptor polymorphisms | Physics | 3 | Expired |
| US7211386B2 | Alpha-2A-adrenergic receptor polymorphisms | Chemistry; Metallurgy | 3 | Expired |
| US8080578B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 1 | Active |
| US8916603B2 | Methods for treatment with bucindolol based on genetic targeting | Physics | 0 | Active |
| US12024502B2 | Biased adrenergic agonists | Chemistry; Metallurgy | 0 | Active |
| US10927375B1 | Compositions and methods to reduce beta-agonist-mediated tachyphylaxis | Chemistry; Metallurgy | 0 | Active |
| US11896644B2 | Inhibition of beta-arrestin oligomerization in tauopathy | Chemistry; Metallurgy | 0 | Active |
| US8530160B2 | G-protein coupled receptor kinase-5 polymorphism | Chemistry; Metallurgy | 0 | Active |
| US12257248B2 | Bronchodilators for treating obstructive lung disease | Human Necessities | 0 | Active |
| US8071287B2 | Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.